Cargando…

Medical Resource Use and Medical Costs for Radiotherapy-Related Adverse Effects: A Systematic Review

SIMPLE SUMMARY: Cancer patients who receive radiotherapy often suffer from adverse effects that require healthcare resources to manage. This study summarized evidence of healthcare resource use and costs related to radiotherapy-induced adverse effects and provided recommendations for including this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yi Hsuan, Molenaar, Dominique, Uyl-de Groot, Carin A., van Vulpen, Marco, Blommestein, Hedwig M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139402/ https://www.ncbi.nlm.nih.gov/pubmed/35626049 http://dx.doi.org/10.3390/cancers14102444

Ejemplares similares

Costs of Newly Funded Proton Therapy Using Time-Driven Activity-Based Costing in The Netherlands
por: Chen, Yi Hsuan, et al.
Publicado: (2023)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

Regulatory Approval, Reimbursement, and Clinical Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Metastatic Breast Cancer in the Netherlands
por: Luyendijk, Marianne, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of MammaPrint(®) to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer
por: Luyendijk, Marianne, et al.
Publicado: (2023)

A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma
por: Seefat, Maarten R., et al.
Publicado: (2021)

Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?
por: Jongbloed, Elisabeth M, et al.
Publicado: (2023)

Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma
por: Blommestein, Hedwig M., et al.
Publicado: (2021)

Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysis
por: Blommestein, Hedwig M., et al.
Publicado: (2019)

Real‐world evidence in health technology assessment of high‐risk medical devices: Fit for purpose?
por: Klein, Philip, et al.
Publicado: (2022)

Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS)
por: Verelst, Silvia G.R., et al.
Publicado: (2018)

Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review
por: Mekonnen, Alemayehu B., et al.
Publicado: (2017)

Cost-effectiveness of first line nivolumab-ipilimumab combination therapy for advanced non-small cell lung cancer: A systematic review and methodological quality assessment
por: Zaim, Remziye, et al.
Publicado: (2023)

Results from Expanded Access Programs: A Review of Academic Literature
por: Polak, Tobias B., et al.
Publicado: (2023)

The cost-effectiveness of (18)FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy
por: van Hooren, Addy C. G., et al.
Publicado: (2008)

The Prevalence of Adverse Drug Reactions and Adverse Drug Events from Heart Failure Medications in Frail Older Adults: A Systematic Review
por: Duong, Mai H., et al.
Publicado: (2022)

Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review
por: Njie, Gibril J., et al.
Publicado: (2015)

A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)
por: Urbich, Michael, et al.
Publicado: (2020)

Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis
por: Baldwin, Zachary, et al.
Publicado: (2022)

Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews
por: Monga, Neerav, et al.
Publicado: (2020)

Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments
por: De Groot, S., et al.
Publicado: (2017)

Changes in survival in de novo metastatic cancer in an era of new medicines
por: Luyendijk, Marianne, et al.
Publicado: (2023)

Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma
por: Bakker, LJ, et al.
Publicado: (2023)

Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy
por: Ansaripour, Amir, et al.
Publicado: (2017)

Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands
por: Xander, Nicolas S. H., et al.
Publicado: (2023)

Systematic reviews as a “lens of evidence”: Determinants of cost‐effectiveness of breast cancer screening
por: Mandrik, Olena, et al.
Publicado: (2019)

Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management
por: Paracha, Noman, et al.
Publicado: (2021)

Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review
por: Alghamdi, Anwar A., et al.
Publicado: (2019)

Associations Between Anticholinergic Medication Exposure and Adverse Health Outcomes in Older People with Frailty: A Systematic Review and Meta-analysis
por: Mehdizadeh, David, et al.
Publicado: (2021)

Impact of financial medication assistance on medication adherence: a systematic review
por: Hung, Anna, et al.
Publicado: (2021)

Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab
por: Franken, Margreet, et al.
Publicado: (2020)

Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma
por: Monga, Neerav, et al.
Publicado: (2020)

Interventions to reduce medication errors in adult medical and surgical settings: a systematic review
por: Manias, Elizabeth, et al.
Publicado: (2020)

Medication-related problems in critical care survivors: a systematic review
por: Short, Abigail, et al.
Publicado: (2023)

Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review
por: Alqenae, Fatema A., et al.
Publicado: (2020)

Processing medical data: a systematic review
por: Adane, Kasaw, et al.
Publicado: (2013)

Telemedicine for medical abortion: a systematic review
por: Endler, M, et al.
Publicado: (2019)

Misuse of Anticholinergic Medications: A Systematic Review
por: Chiappini, Stefania, et al.
Publicado: (2022)

Adverse Childhood Experiences Are Associated with Reduced Psychological Resilience in Youth: A Systematic Review and Meta-Analysis
por: Morgan, Cyleen A., et al.
Publicado: (2021)

A Systematic Review on Nerve-Related Adverse Effects following Mandibular Nerve Block Anesthesia
por: Aquilanti, Luca, et al.
Publicado: (2022)

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks
por: van der Gronde, Toon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6meh3g8nfkb6ahnn1agqgmpm69